# A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients

> **NCT02765815** · PHASE4 · WITHDRAWN · sponsor: **Holy Cross Hospital, Florida**

## Conditions studied

- Osteoarthritis, Knee
- Arthroplasty, Replacement, Knee

## Interventions

- **DRUG:** Liposomal bupivacaine, 266mg
- **DRUG:** Bupivacaine 0.5 % with Epinephrine
- **DRUG:** Ketorolac 30mg
- **DRUG:** Morphine 10mg
- **DRUG:** Bupivacaine 0.25% with Epinephrine

## Key facts

- **NCT ID:** NCT02765815
- **Lead sponsor:** Holy Cross Hospital, Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-02
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** competing protocol
- **Last updated:** 2017-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02765815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02765815, "A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02765815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*